Immgolis Purple Book BLA 761452

BLA number
761452
Proprietary names
Immgolis, Immgolis Intri
Proper names
golimumab-sldi
Applicant
Accord BioPharma Inc.
Center
CDER
First observed release
2026-07-01
Latest observed release
2026-07-01
Newest archive release
2026-07-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Immgolisgolimumab-sldi351(k) Interchangeable50MG/0.5ML (100MG/ML)InjectionSubcutaneousPre-Filled SyringeRxLicensed2026-05-15
002Immgolisgolimumab-sldi351(k) Interchangeable100MG/MLInjectionSubcutaneousPre-Filled SyringeRxLicensed2026-05-15
003Immgolis Intrigolimumab-sldi351(k) Interchangeable50MG/4ML (12.5MG/ML)InjectionIntravenousSingle-Dose VialRxLicensed2026-05-15

Reference Biological Product#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125289Simponigolimumab351(a)Rx2026-07-01
125433Simponi Ariagolimumab351(a)Rx2026-07-01

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2026-07-01N001Immgolis351(k) InterchangeableRxAccord BioPharma Inc.
2026-07-01N002Immgolis351(k) InterchangeableRxAccord BioPharma Inc.
2026-07-01N003Immgolis Intri351(k) InterchangeableRxAccord BioPharma Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2026-07-01001Immgolis351(k) InterchangeableRxLicensed2026-05-15
2026-07-01002Immgolis351(k) InterchangeableRxLicensed2026-05-15
2026-07-01003Immgolis Intri351(k) InterchangeableRxLicensed2026-05-15